Cite

    Mehta, K. et al. (2015). Impact of annual hospital volume of high dose interleukin-2 infusions on in-patient mortality in patients with melanoma and renal cell carcinoma. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].